Cargando…

The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

BACKGROUND: Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-vaccine immunity, and risk factors of non-protective levels of antibodies again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostik, Mikhail M., Lubimova, Natalia A., Fridman, Irina V., Goleva, Olga V., Kharit, Susanna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256221/ https://www.ncbi.nlm.nih.gov/pubmed/34225748 http://dx.doi.org/10.1186/s12969-021-00594-2

Ejemplares similares

Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
por: Sorokina, Lubov S., et al.
Publicado: (2021)

Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data
por: Makarova, Elizaveta, et al.
Publicado: (2023)

Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2011)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Arthritis
por: Alfayadh, Naba M., et al.
Publicado: (2020)

Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa
por: Weakley, Kate, et al.
Publicado: (2012)

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents
por: Paradis, Erin M., et al.
Publicado: (2021)

Association of the polymorphisms P53 gene with juvenile idiopathic arthritis in children Russian Fedration
por: Kozhevnikov, Alexey N, et al.
Publicado: (2011)

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
por: Weakley, Kate, et al.
Publicado: (2011)

Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD
por: Boldingh, AM, et al.
Publicado: (2011)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis: The Results from a Retrospective Cohort Tertial Center Study
por: Artamonov, Artem K., et al.
Publicado: (2023)

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
por: Minden, Kirsten, et al.
Publicado: (2014)

Juvenile idiopathic arthritis with systemic onset with inflammatory bone lesions: two case reports of patients successfully treated with canakinumab and experience gained from literature
por: Alexeeva, Ekaterina I., et al.
Publicado: (2023)

Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis—A observational study from two pediatric rheumatology centres in Poland
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2023)

Genetic polymorphism of COL1A1 gene and bone mineralisation in juvenile idiopathic arthritis
por: Kostik, MM, et al.
Publicado: (2011)

The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children
por: Kostik, MM, et al.
Publicado: (2008)

The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Nikishina, Irina, et al.
Publicado: (2018)

The Russian vaccine for COVID-19
por: Burki, Talha Khan
Publicado: (2020)

Autoimmune response following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis
por: Aikawa, Nadia E, et al.
Publicado: (2011)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
por: Camacho-Lovillo, M. S., et al.
Publicado: (2017)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.
por: Kompier, Ronald, et al.
Publicado: (2022)

Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre
por: Goirand, Maxime, et al.
Publicado: (2018)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Russian vaccines against especially dangerous bacterial pathogens
por: Feodorova, Valentina A, et al.
Publicado: (2014)

Reindeer Anthrax in the Russian Arctic, 2016: Climatic Determinants of the Outbreak and Vaccination Effectiveness
por: Liskova, Elena A., et al.
Publicado: (2021)

Juvenile idiopathic arthritis-associated uveitis
por: Clarke, Sarah L. N., et al.
Publicado: (2016)

Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience
por: Abdelgalil, Abobakr A., et al.
Publicado: (2022)

Juvenile Idiopathic Arthritis Associated Uveitis
por: Carlsson, Emil, et al.
Publicado: (2021)

Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program
por: Tarasov, Mikhail, et al.
Publicado: (2020)

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

Preliminary study of regionalised centre-of-pressure analysis in patients with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2012)

Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis – single-centre experience
por: Roszkiewicz, Justyna, et al.
Publicado: (2018)

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups
por: Boey, Lise, et al.
Publicado: (2020)

B-Cell Pathology in Juvenile Idiopathic Arthritis
por: Wiegering, V., et al.
Publicado: (2010)

Retrospective Study of the Clinical Epidemiological Characteristics of Pertussis in Infants Prior to Their First Vaccination in the Russian Federation
por: Lobzin, Yury V., et al.
Publicado: (2015)

The Moderating Effect of Vaccine Hesitancy on the Relationship between the COVID-19 Vaccine Coverage Index and Vaccine Coverage
por: Tolley, Annalise Julia, et al.
Publicado: (2023)

Evaluation of vaccination coverage in heart failure patients in a tertiary center
por: Maire, Adrien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l3gpb36ip5c23jhmm852jtgpkn